BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cervello M, Foderà D, Florena AM, Soresi M, Tripodo C, D’Alessandro N, Montalto G. Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis. World J Gastroenterol 2005; 11(30): 4638-4643 [PMID: 16094702 DOI: 10.3748/wjg.v11.i30.4638]
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4638.htm
Number Citing Articles
1
Girolamo Ranieri, Michele Ammendola, Ilaria Marech, Annamaria Laterza, Ines Abbate, Caroline Oakley, Angelo Vacca, Rosario Sacco, Cosmo Damiano Gadaleta. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patientsWorld Journal of Gastroenterology 2015; 21(19): 6018-6025 doi: 10.3748/wjg.v21.i19.6018
2
Nabil M. Abdel-Hamid, Amer Hasan Abdullah. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinomaClinical and Experimental Medicine 2019; 19(1): 115 doi: 10.1007/s10238-018-0537-y
3
Xiao-Dong Zhu, Ju-Bo Zhang, Peng-Yuan Zhuang, Hong-Guang Zhu, Wei Zhang, Yu-Quan Xiong, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, Hui-Chuan Sun. High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular CarcinomaJournal of Clinical Oncology 2008; 26(16): 2707 doi: 10.1200/JCO.2007.15.6521
4
F. Millanta, G. Andreani, G. Rocchigiani, D. Lorenzi, A. Poli. Correlation Between Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression in Canine and Feline Squamous Cell CarcinomasJournal of Comparative Pathology 2016; 154(4): 297 doi: 10.1016/j.jcpa.2016.02.005
5
D. Hattis, M. Chu, N. Rahmioglu, R. Goble, P. Verma, K. Hartman, M. Kozlak. A Preliminary Operational Classification System for Nonmutagenic Modes of Action for CarcinogenesisCritical Reviews in Toxicology 2009; 39(2): 97 doi: 10.1080/10408440802307467
6
Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenases in hepatocellular carcinomaWorld Journal of Gastroenterology 2006; 12(32): 5113-5121 doi: 10.3748/wjg.v12.i32.5113
7
Patricia de la Cruz-Ojeda, Rocío Flores-Campos, Sandra Dios-Barbeito, Elena Navarro-Villarán, Jordi Muntané. Role of Nitric Oxide in Gene Expression Regulation during Cancer: Epigenetic Modifications and Non-Coding RNAsInternational Journal of Molecular Sciences 2021; 22(12): 6264 doi: 10.3390/ijms22126264
8
Hiroshi Kono, Hideki Fujii, Shinji Furuya, Michio Hara, Kazuyoshi Hirayama, Yoshihiro Akazawa, Yuuki Nakata, Masato Tsuchiya, Naohiro Hosomura, Chao Sun. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(39): 8779-8789 doi: 10.3748/wjg.v22.i39.8779
9
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?Digestive and Liver Disease 2010; 42(8): 529 doi: 10.1016/j.dld.2010.02.016
10
Magda SA Abdeltawab, Iman R. Abdel-Shafi, Basma Emad Aboulhoda, Amal M. Mahfoz, Alshaimaa MR Hamed. The neuroprotective potential of curcumin on T. Spiralis infected miceBMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04399-0
11
Jessica L. Petrick, Vikrant V. Sahasrabuddhe, Andrew T. Chan, Michael C. Alavanja, Laura E. Beane-Freeman, Julie E. Buring, Jie Chen, Dawn Q. Chong, Neal D. Freedman, Charles S. Fuchs, John Michael Gaziano, Edward Giovannucci, Barry I. Graubard, Albert R. Hollenbeck, Lifang Hou, Eric J. Jacobs, Lindsay Y. King, Jill Koshiol, I-Min Lee, Martha S. Linet, Julie R. Palmer, Mark P. Purdue, Lynn Rosenberg, Catherine Schairer, Howard D. Sesso, Alice J. Sigurdson, Jean Wactawski-Wende, Anne Zeleniuch-Jacquotte, Peter T. Campbell, Katherine A. McGlynn. NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling ProjectCancer Prevention Research 2015; 8(12): 1156 doi: 10.1158/1940-6207.CAPR-15-0126
12
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinomaClinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
13
A Fernández-Alvarez, C Llorente-Izquierdo, R Mayoral, N Agra, L Boscá, M Casado, P Martín-Sanz. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaOncogenesis 2012; 1(7): e23 doi: 10.1038/oncsis.2012.23
14
Magda Hamzawy, Laila Elsaid, Asmaa Shams, Laila Rashid, Soheir Mahfouz, Nivin Sharawy. Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat DietJournal of Clinical and Experimental Hepatology 2015; 5(1): 14 doi: 10.1016/j.jceh.2014.12.010
15
Lydia Giannitrapani, Sabrina Ingrao, Maurizio Soresi, Ada Maria Florena, Emanuele La Spada, Luigi Sandonato, Natale D'Alessandro, Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenase‐2 Expression in Chronic Liver Diseases and Hepatocellular CarcinomaAnnals of the New York Academy of Sciences 2009; 1155(1): 293 doi: 10.1111/j.1749-6632.2009.03698.x
16
Chun-Chieh Yeh, Jaw-Town Lin, Long-Bin Jeng, Hsiu J. Ho, Horng-Ren Yang, Ming-Shiang Wu, Ken N. Kuo, Chun-Ying Wu. Nonsteroidal Anti-inflammatory Drugs Are Associated With Reduced Risk of Early Hepatocellular Carcinoma Recurrence After Curative Liver ResectionAnnals of Surgery 2015; 261(3): 521 doi: 10.1097/SLA.0000000000000746
17
Fei Wang, Hongxia Ma, Zhaoguo Liu, Wei Huang, Xiaojing Xu, Xuemei Zhang. α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in miceBiomedicine & Pharmacotherapy 2017; 92: 672 doi: 10.1016/j.biopha.2017.05.129
18
Jeng-Wei Tjiu, Jau-Shiuh Chen, Chia-Tung Shun, Sung-Jan Lin, Yi-Hua Liao, Chia-Yu Chu, Tsen-Fang Tsai, Hsien-Ching Chiu, Yang-Shia Dai, Hiroyasu Inoue, Pan-Chyr Yang, Min-Liang Kuo, Shiou-Hwa Jee. Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 InductionJournal of Investigative Dermatology 2009; 129(4): 1016 doi: 10.1038/jid.2008.310
19
Meng Lu, Jiao Wu, Feng He, Xi-Long Wang, Can Li, Zhi-Nan Chen, Huijie Bian. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinomaJournal of Molecular Histology 2015; 46(1): 79 doi: 10.1007/s10735-014-9602-3
20
Chien-Yi Tung, Chih-Hung Jen, Ming-Ta Hsu, Hsei-Wei Wang, Chi-Hung Lin. A novel regulatory event-based gene set analysis method for exploring global functional changes in heterogeneous genomic data setsBMC Genomics 2009; 10(1) doi: 10.1186/1471-2164-10-26
21
Chun-Xia Ren, Rui-Xue Leng, Yin-Guang Fan, Hai-Feng Pan, Bao-Zhu Li, Chang-Hao Wu, Qiang Wu, Na-Na Wang, Qi-Ru Xiong, Xiao-Ping Geng, Dong-Qing Ye. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic valueOncology Reports 2017; 38(2): 886 doi: 10.3892/or.2017.5738
22
M. Bardagí, D. Fondevila, L. Ferrer. Immunohistochemical Detection of COX-2 in Feline and Canine Actinic Keratoses and Cutaneous Squamous Cell CarcinomaJournal of Comparative Pathology 2012; 146(1): 11 doi: 10.1016/j.jcpa.2011.03.012
23
Li-Jie Wang, Li Bai, Dan Su, Ting Zhang, Zhi-Yuan Mao. Proinflammatory conditions promote hepatocellular carcinoma onset and progression via activation of Wnt and EGFR signaling pathwaysMolecular and Cellular Biochemistry 2013; 381(1-2): 173 doi: 10.1007/s11010-013-1700-0
24
Jason Foster, Jennifer Black, Charles LeVea, Thaer Khoury, Boris Kuvshinoff, Miland Javle, John F. Gibbs. COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of SurvivalAnnals of Surgical Oncology 2007; 14(2): 752 doi: 10.1245/s10434-006-9123-8
25
Mario M. Alba, Brandon Ebright, Brittney Hua, Ielyzaveta Slarve, Yiren Zhou, Yunyi Jia, Stan G. Louie, Bangyan L. Stiles. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer developmentFrontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098467
26
Jun Yu, Joseph JY Sung. Cyclooxygenase‐2 (COX‐2): Does it matter in patients with HCV‐related liver cirrhosis?Journal of Gastroenterology and Hepatology 2007; 22(8): 1169 doi: 10.1111/j.1440-1746.2007.04998.x
27
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 121 doi: 10.1007/978-3-319-26956-6_5
28
VERONICA GOFFREDO, COSMO DAMIANO GADALETA, ANNAMARIA LATERZA, ANGELO VACCA, GIROLAMO RANIERI. Tryptase serum levels in patients suffering from hepatocellular carcinoma undergoing intra-arterial chemoembolization: Possible predictive role of response to treatmentMolecular and Clinical Oncology 2013; 1(2): 385 doi: 10.3892/mco.2013.59
29
Xiaoqiang Gao, Shi Zuo. Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cellsClinical and Experimental Medicine 2023; 23(6): 1881 doi: 10.1007/s10238-023-01015-2
30
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_5-1
31
Lydia Giannitrapani, Maurizio Soresi, Sabrina Ingrao, Emanuele La Spada, Onofrio Vuturo, Ada Maria Florena, Melchiorre Cervello, Giuseppe Montalto. Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology 2007; 19(11): 927 doi: 10.1097/MEG.0b013e3282f01e91
32
Vikrant V. Sahasrabuddhe, Munira Z. Gunja, Barry I. Graubard, Britton Trabert, Lauren M. Schwartz, Yikyung Park, Albert R. Hollenbeck, Neal D. Freedman, Katherine A. McGlynn. Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular CarcinomaJNCI: Journal of the National Cancer Institute 2012; 104(23): 1808 doi: 10.1093/jnci/djs452
33
Melchiorre Cervello, Dimcho Bachvarov, Nadia Lampiasi, Antonella Cusimano, Antonina Azzolina, James A. McCubrey, Giuseppe Montalto, Manlio Vinciguerra. Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer CellsPLoS ONE 2013; 8(6): e65569 doi: 10.1371/journal.pone.0065569
34
Katherine A. McGlynn, Jessica L. Petrick, W. Thomas London. Global Epidemiology of Hepatocellular CarcinomaClinics in Liver Disease 2015; 19(2): 223 doi: 10.1016/j.cld.2015.01.001
35
Hugo Gregório, Teresa P. Raposo, Felisbina L. Queiroga, Justina Prada, Isabel Pires. Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and T-lymphocyte infiltration in canine melanocytic tumoursMelanoma Research 2016; 26(4): 338 doi: 10.1097/CMR.0000000000000262
36
A. M. R. Hamed, I. R. Abdel-Shafi, M. D. A. Elsayed, A. M. Mahfoz, S. E. Tawfeek, M. S. A. Abdeltawab. Investigation of the effect of curcumin on oxidative stress, local inflammatory response, COX-2 expression, and microvessel density in Trichinella spiralis induced enteritis, myositis and myocarditis in miceHelminthologia 2022; 59(1): 18 doi: 10.2478/helm-2022-0002
37
Pei-Chang Lee, Chiu-Mei Yeh, Yu-Wen Hu, Chun-Chia Chen, Chia-Jen Liu, Chien-Wei Su, Teh-Ia Huo, Yi-Hsiang Huang, Yee Chao, Tzeng-Ji Chen, Han-Chieh Lin, Jaw-Ching Wu. Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver ResectionAnnals of Surgical Oncology 2016; 23(S5): 874 doi: 10.1245/s10434-016-5520-9
38
Xueyan Jiang, Yaodong Ping, Yuan Chen, Benben Zhu, Rong Fu, Yiwei Hao, Lei Fan. A study on construction of a prognosis model for liver cancer based on analgesic targets and screening therapeutic drugsGenes & Genomics 2024; 46(7): 831 doi: 10.1007/s13258-024-01515-9
39
Daria Capece, Mariafausta Fischietti, Daniela Verzella, Agata Gaggiano, Germana Cicciarelli, Alessandra Tessitore, Francesca Zazzeroni, Edoardo Alesse. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated MacrophagesBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/187204
40
Osmar Damasceno Ribeiro, Nathalie Henriques Silva Canedo, Vera Lucia Pannain. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological featuresClinics 2016; 71(11): 639 doi: 10.6061/clinics/2016(11)04
41
Melchiorre Cervello, James A. McCubrey, Antonella Cusimano, Nadia Lampiasi, Antonina Azzolina, Giuseppe Montalto. Targeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget 2012; 3(3): 236 doi: 10.18632/oncotarget.466
42
Mehmet ßahin, Emel ßahin, Saadet Gümüşlü. Cyclooxygenase-2 in Cancer and AngiogenesisAngiology 2009; 60(2): 242 doi: 10.1177/0003319708318378
43
SK Hasan, R Khan, N Ali, AQ Khan, MU Rehman, M Tahir, A Lateef, S Nafees, SJ Mehdi, S Rashid, A Shahid, S Sultana. 18-β Glycyrrhetinic acid alleviates 2-acetylaminofluorene-induced hepatotoxicity in Wistar ratsHuman & Experimental Toxicology 2015; 34(6): 628 doi: 10.1177/0960327114554045
44
Snehal S. Patel, Richa Tripathi, Vishal K. Chavda, Jignasa K. Savjani. Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory PropertyAnti-Cancer Agents in Medicinal Chemistry 2020; 20(8): 998 doi: 10.2174/1871520620666200415100614